Архитектура Аудит Военная наука Иностранные языки Медицина Металлургия Метрология Образование Политология Производство Психология Стандартизация Технологии |
Побочные и токсические эффекты.
Острая интоксикация литием Schou M. The recognition and management of lithium intoxication. In: Johnson FN, ed. Handbook of lithium therapy. Lancaster, England: MTP Press, 1980. Simard M, Gumbiner B, Lee A, et al. Lithium carbonate intoxication: a case report and review of the literature. Arch Intern Med 1989; 149: 36. Действие лития на почки Battle DC, von Riotte AB, Gavira M, et al. Amelioration of polyuria by amiloride in patients receiving long-term lithium therapy. N Engl J Med 1985; 312: 408. Bendz H, Aurell M, Balldin J, et al. Kidney damage in long-term lithium patients: a cross-sectional study of patients with 15 years or more on lithium. Nephrol Dialysis Transplant 1994; 9: 1250. Bowen RC, Grof P, Grof E. Less frequent lithium administration and lower urine volume. Am J Psychiatry 1991; 148: 189. De Paulo JR Jr, Correa El, Sapir DG. Renal function and lithium: a longitudinal study. Am J Psychiatry 1986; 143: 892. Hetmar О, Brun С, Clemmsen L, et al. Lithium: long-term effects on the kidney: II. Structural changes. J Psychiatr Res 1987; 21: 279. Hetmar O, Clemmsen L, Ladefoged J, et al. Lithium: long-term effects on the kidney: III. Prospective study. Acta Psychiatr Scand 1987; 75: 251. Kosten TR, Forrest JN. Treatment of severe lithium-induced polyuria with amiloride. Am J Psychiatry 1986; 143: 1563. Plenge P, Raaelson OJ. Lithium treatment: Does the kidney prefer one daily dose instead of two? Acta Psychiatr Scand 1982; 66: 121. Wood IK, Parmelee DX, Foreman JW. Lithium induced nephrotic syndrome. Am J Psychiatry 1989; 146: 84. Неврологическая токсичность Apte SN, Langston JW. Permanent neurological deficits due to lithium toxicity. Ann Neurol 1983; 13: 452. Engelsmann F, Katz J, Ghadirian AM, et al. Lithium and memory: a long-term follow-up study. J Clin Psychopharmacol 1988; 8: 207. Joffe RT, MacDonald C, Kutcher SP. Lack of differential cognitive effects of lithium and carbamazepine in bipolar affective disorder. J Clin Psychopharmacol 1988; 8: 425. Saul RF, Hamberger HA, Selhorst JB. Pseudotumor cerebri secondary to lithium carbonate. JAMA 1985; 253: 2869. Schou M. Long-lasting neurological sequelae after lithium intoxication. Acta Psychiatr Scand 1984; 70: 594. Другие побочные эффекты Deandrea D, Walker N, Mehlmauer M, et al. Dermatological reactions to lithium: a critical review of the literature. J Clin Psychopharmacol 1982; 2: 199. Franks RD, Dubovsky SL, Lifshitz M, et al. Long-term lithium carbonate therapy causes hyperparathyroidism. Arch Gen Psychiatry 1982; 39: 1074. Garland EJ, Remick RA, Zis AP. Weight gain with antidepressants and lithium. J Clin Psychopharmacol 1988; 8: 323. Lyman GH, Williams CC, Dinwoodie WR, et al. Sudden death in cancer patients receiving lithium. J Clin Oncol 1984; 2: 1270. Mitchell JE, Mackenzie ТВ. Cardiac effects of lithium therapy in man: a review. J Clin Psychiatry 1982; 43: 47. Susman VL, Adonizio G. Reintroduction of neuroleptic malignant syndrome by lithium. J Clin Psychopharmacol 1987; 7: 339. Yassa R, Saunders A, Nastase C, et al. Lithium-induced thyroid disorders: a prevalence study. J Clin Psychiatry 1988; 48: 14. Лекарственные взаимодействия. Miller F, Menmger J. Lithium-neuroleptic neurotoxicity is dose dependent. J Clin Psychopharmacol 1987; 7: 89. Ragheb M. The clinical significance of lithium-nonsteroidal antiinflammatory drug interactions. J Clin Psychopharmacol 1990; 10: 350. Применение при беременности. Cohen LS, Friedman JM, Jefferson JW, et al. A reevaluation of risk of in utero exposure to lithium. JAMA 1994; 271: 146. Zalstein E, Koren G, Einarson T, Freedom RM. A case control study on the association between 1st trimester exposure to lithium and Ebstein's anomaly. Am J Cardiol 1990; 65: 817. Вальпроевая кислота. Применение при биполярном расстройстве Bowden CL, Brugger AM, Swann AC. et al. Efficacy of divalproex vs. lithum and placebo in the treatment of mania. JAMA 1994; 271: 918. Bowden CL, Brugger AM, Swann AC, et al. Efficacy of divalproex vs. lithium and placebo in the treatment of mania The Depakote Mania Study Group. JAMA 1994; 271: 918. Calabrese JR, Markovitz P, Kimmel SE, et al. Spectrum of efficacy of valproate in 78 rapid-cycling bipolar patients. J Clin Psychopharmacol 1992; 12(suppl): 53. Swann AC, Bowden CL, Calabrese JR, et al. Differential effect of number of previous episodes of affective disorder on response to lithium or divalproex in acute mania. Am J Psychiatry 1999; 156: 1264. Swann AC, Bowden CL, Morris D, et al. Depression during mania. Treatment response to lithium or divalproex. Arch Gen Psychiatry 1997; 54: 37. Побочные и токсические эффекты Dreifuss FE. Valproic acid hepatic fatalities: revised table. Neurology 1989; 39: 1558. Dreifuss FE, Langer DH, Moline KA, et al. Valproic acid hepatic fatalities. II: U.S. experience since 1984. Neurology 1989; 39: 201. Smith MC, Black TP. Convulsive disorders: toxicity of anticonvulsants. Clin Pharmacol 1991; 14: 97. Wisner KL, Perel JM. Serum levels of valproate and carbamazepine in breastfeeding mother-infant pairs. J Clin Psychopharmacol 1998; 18: 167. Карбамазепин. Применение при биполярном расстройстве Lusznat RM, Murphy DP, Nunn CMH. Carbamazepine vs. lithium in the treatment and prophylaxis of mania. Br J Psychiatry 1986; 153: 198. Placidi GF, Lenzi A, Lazzerini F, et al. The comparative efficacy and safety of carbamazepine versus lithium: a randomized double-blind three-year trial in 83 patients. J Clin Psychiatry 1986; 47: 490. Small JG, Klapper MH, Milstein V, et al. Carbamazepine compared with lithium in the treatment of mania. Arch Gen Psychiatry 1991; 48: 915. Stuppaeck C, Barnas C, Miller C, et al. Carbamazepine in the prophylaxis of mood disorders. J Clin Psychopharmacol 1990; 10: 39. Применение при других психических заболеваниях Malcolm R, Ballenger JC, Sturgis ET, et al. Double-blind controlled trial comparing carbamazepine to oxazepam treatment of alcohol withdrawal. Am J Psychiatry 1989; 146: 617. Schweizer E, Rickels K, Case WG, et al. Carbamazepine treatment in patients discontinuing long-term benzodiazepine therapy. Arch Gen Psychiatry 1991; 48: 448. Sramek J, Herrera J, Costa J, et al. A carbamazepine trial in chronic treatment refractory schizophrenia. Am J Psychiatry 1988; 145: 748. Uhde TW, Stein MB, Post RM. Lack of efficacy of carbamazepine in the treatment of panic disorder. Am J Psychiatry 1988; 145: 1104. Побочные и токсические эффекты Hart RG, Easton JD. Carbamazepine and hematological monitoring. Ann Neurol 1982; 11: 309. Heh CWC, Sramek J, Herrera J, et al. Exacerbation of psychosis after discontinuation of carbamazepine treatment. Am J Psychiatry 1988; 145: 878. Joffe RT, MacDonald C, Kutcher SP. Lack of differential cognitive effects of lithium and carbamazepine in bipolar affective disorder. J Clin Psychopharmacol 1988; 8: 425. Joffe RT, Post RM, Roy-Byrne PP, et al. Hematological effects of carbamazepine in patients with affective illness. Am J Psychiatry 1985; 142: 1196. Roy-Byrne PP, Joffe RT, Uhde TW, et al. Carbamazepine and thyroid function in affectively ill patients. Arch Gen Psychiatry 1984; 41: 1150. Trimble MR, Thompson PJ. Anticonvulsant drugs, cognitive function, and behavior. Epilepsia 1983; 24(suppl 1): 55. Лекарственные взаимодействия Arana GW, Goff D, Friedman H, et al. Does carbamazepine induced lowering of haloperidol levels worsen psychotic symptoms? Am J Psychiatry 1986; 143: 650. Ketter ТА, Post RM, Worthington K. Principles of clinically important drug interactions with carbamazepine: Parts I and II. J Clin Psychopharmacol 1991; 11: 198. Применение при беременности Altshuler LL, Cohen L, Szuba MP, et al. Pharmacologic management of psychiatric illness during pregnancy dilemmas and guidelines. Am J Psychiatry 1996; 152: 592. Jones KL, Johnson KA, Adams J. Pattern of malformations in children of women treated with carbamazepine during pregnancy. N Engl J Med 1989; 320: 1661. Rosa FW. Spina bifida in infants of women treated with carbamazepine during pregnancy. N Engl J Med 1991; 324: 674. Другие противосудорожные препараты. Calabrese JR, Bowden CL, McElroy SL, et al. Spectrum of activity of lamotrigine in treatment refractory bipolar disorder. Am J Psychiatry 1999; 156: 1019. Calabrese JR, Bowden CL, Sachs GS, et al. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. J Clin Psychiatry 1999; 60: 79. Marcotte D. Use of topiramate, a new anti-epileptic as a mood stabilizer. Affect Disord 1998; 50: 245. Young LT, Robb JC, Hasey GM, et al. Gabapentin as an adjunctive treatment in bipolar disorder. J Affect Disord 1999; 55: 73. Другие препараты. Ghaemi SN, Goodwin FK. Use of atypical agents in bipolar and schizoaffective disorders: review of the empirical literature. J Clin Psychopharmacol 1999; 12(suppl): 57. Marcotte D. Use of topiramate, a new anti-epileptic as a mood stabilizer. J Affect Disord 1998; 50: 245. Suppes T, Webb A, Paul B, et al. Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania. Am J Psychiatry 1999; 156: 1164. Stoll AL, Severus WE, Freeman MP, et al. Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial. Arch Gen Psychiatry 1999; 56: 407. Tohen M, Sanger TM, McElroy SL, et al. Olanzapine versus placebo in the treatment of acute mania. Am J Psychiatry 1999; 156: 702. Популярное:
|
Последнее изменение этой страницы: 2017-03-09; Просмотров: 537; Нарушение авторского права страницы